SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,152 | 0.0% | 403 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $46,152 | -16.9% | 403 | 0.0% | 0.01% | -25.0% |
| Q1 2023 | $55,545 | -22.3% | 403 | -27.0% | 0.02% | -33.3% |
| Q4 2022 | $71,528 | +49.0% | 552 | -13.9% | 0.02% | +50.0% |
| Q3 2022 | $48,000 | -4.0% | 641 | 0.0% | 0.02% | +33.3% |
| Q2 2022 | $50,000 | 0.0% | 641 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $50,000 | – | 641 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |